Finzati - Logo
CVM logo

CEL-SCI Corporation

CVM • Biotechnology
$1.63
▲ +0.02 (+1.24%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$10.79M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.59Healthy liquidity · 2.26Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 18, 2026, 3:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.63
Change1.24%
Market Cap$10.79M
52W Range0.89 - 13.48
Beta0.56
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.59
Current Ratio2.26
Quick Ratio2.20
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Manageable debt level · 0.59Healthy liquidity · 2.26Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 12/8/1983
Industry: Biotechnology
P/B i: 2.34
Debt / Equity i: 0.59
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.59
Current Ratio: 2.26
Quick Ratio: 2.20
Status: Good

Insider Transactions

Recent executive and insider activity

KERSTEN GEERT R
Transaction: 08/14/2026
BUY
Change
+300,000
Price
$1.49
Filing
08/17/2026
Type
BUY
PRICHEP PATRICIA B
Transaction: 08/14/2026
BUY
Change
+225,000
Price
$1.49
Filing
08/17/2026
Type
BUY
TALOR EYAL
Transaction: 08/14/2026
BUY
Change
+250,000
Price
$1.49
Filing
08/17/2026
Type
BUY